These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1103962)

  • 1. Fibrin/fibrinogen degradation products in amniotic fluid.
    Purdie DW; Howie PW; Edgar W; Prentice CR
    Br J Obstet Gynaecol; 1975 Oct; 82(10):845-6. PubMed ID: 1103962
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Fibrin/fibrinogen degradation products in amniotic fluid.
    Purdie DW; Howie PW; Edgar W; Prentice CR
    Thromb Diath Haemorrh; 1975 Nov; 34(2):585. PubMed ID: 1198491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha fetoproteins and fibrinogen degradation products (FDP) in amniotic fluid].
    Diani F; Conte N; Carozzi S
    Boll Soc Ital Biol Sper; 1978 May; 54(9):824-6. PubMed ID: 81066
    [No Abstract]   [Full Text] [Related]  

  • 4. [C3 component, fibrinogen and fibrin degradation products as well as plasminogen in amniotic fluid].
    Cisło M
    Pol Tyg Lek; 1978 Jan; 33(4):155-7. PubMed ID: 652636
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: F.D.P. in amniotic fluid as marker for neural-tube defects.
    Weiss RR; Macri JN; Merskey C
    Lancet; 1976 Feb; 1(7954):304. PubMed ID: 55614
    [No Abstract]   [Full Text] [Related]  

  • 6. Amniotic fluid protein in pregnancies complicated by anencephaly.
    Brock DJ; Nelson MM
    J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):177-81. PubMed ID: 4595297
    [No Abstract]   [Full Text] [Related]  

  • 7. Decidual, amniotic fluid, maternal and fetal prolactin in normal and abnormal pregnancies.
    Luciano AA; Varner MW
    Obstet Gynecol; 1984 Mar; 63(3):384-8. PubMed ID: 6366659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoacid composition of amniotic fluid in central-nervous-system malformations.
    Emery AE; Burt D; Scrimgeour JB
    Lancet; 1973 May; 1(7810):970-1. PubMed ID: 4121590
    [No Abstract]   [Full Text] [Related]  

  • 9. Amniotic fluid composition in malformations of the fetal central nervous system.
    Emery AE; Brock DJ; Burt D; Eccleston D
    J Obstet Gynaecol Br Commonw; 1974 Jul; 81(7):512-6. PubMed ID: 4602159
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular nature of alpha-fetoprotein in anencephaly and spina bifida.
    Brock DJ
    Clin Chim Acta; 1974 Dec; 57(3):315-20. PubMed ID: 4215603
    [No Abstract]   [Full Text] [Related]  

  • 11. Amniotic fluid oestriol concentration during the last trimester of pregnancy. II. Perinatal mortality and morbidity.
    Jorgensen PI
    Acta Obstet Gynecol Scand Suppl; 1974; 29():29-36. PubMed ID: 4526164
    [No Abstract]   [Full Text] [Related]  

  • 12. Amniotic fluid composition in malformation of the central nervous sytem.
    Emery AE; Eccleston D; Scrimgeour JB; Johnstone M
    J Obstet Gynaecol Br Commonw; 1972 Feb; 79(2):154-8. PubMed ID: 4556725
    [No Abstract]   [Full Text] [Related]  

  • 13. Raised amniotic-fluid F.D.P. in fetal neural-tube anomalies.
    Purdie DW; Howie PW; Edgar W; Forbes CD; Prentice CR
    Lancet; 1975 May; 1(7914):1013-4. PubMed ID: 48677
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physiology and pathology of the amniotic fluid's formation and resorption].
    Jantzen K
    Gynakol Rundsch; 1968; 5(2):81-96. PubMed ID: 4890219
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of increased fibrin/fibrinogen degradation products and presence of fibrin monomers in pregnant women.
    Svanberg L; Eydal A; Astedt B
    Ann Chir Gynaecol Suppl; 1977; 66(5):247-50. PubMed ID: 596808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular aspects of defibrination in a case of amniotic fluid embolism.
    Graeff H; Hafter R; von Hugo R
    Thromb Haemost; 1977 Oct; 38(3):724-7. PubMed ID: 579518
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of amniotic fluid proteins by isoelectrofocusing (IEF) in pregnancies complicated by polyhydramnios and Rh-sensitization.
    Diani F; Conti I; Felis S; Repetti F; Costa A
    Biol Res Pregnancy Perinatol; 1986; 7(2):56-9. PubMed ID: 3089337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrin degradation products in pregnant women with nephropathies].
    Tsitsiashvili ESh
    Sov Med; 1982; (2):113-4. PubMed ID: 7063962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrolytic and protein components of the amniotic fluid in polyhydramnios].
    Cargnello U; D'Andrea A
    Attual Ostet Ginecol; 1967; 12(2):99-113. PubMed ID: 4880731
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relations between products of fibrin degradation and arterial blood pressure in pregnancy complicated by nephropathy].
    Tsitsiashvili ESh
    Lab Delo; 1982; (4):230-2. PubMed ID: 6177910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.